Study Information
| Title: | Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer  |
| Status: | Recruiting participants |
| Conditions: | Small Cell Lung Cancer |
| Interventions: | Drug: STA-9090 |
| Institutions: | Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital |
| Health Topics: | Adenocarcinoma of the Lung, Lung Cancer Overview, Small Cell Lung Cancer, Squamous cell carcinoma of the lung |
Contact Information
Beth Israel Deaconess Medical Center
Boston, MA 02115
Mark Huberman, MD
Dana Farber Cancer Institute
Boston, MA 02114
Massacusetts General Hospital
Boston, MA 02114
Rebecca Heist, MD